Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT03832400 - Microbial Ecosystem Therapeutics 2 (MET-2) & Ulcerative colitis (UC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview:

NCT03832400 - Microbial Ecosystem Therapeutics 2 (MET-2) & Ulcerative colitis (UC) is a phase 1b, placebo-controlled, randomized multiple dose pilot treatment trial evaluating Microbial Ecosystem Therapeutics 2 (MET-2) or placebo in patients with mild to moderate Ulcerative colitis (UC)

Primary outcome measures:

Microbiologic assessment of fecal deoxyribonucleic acid (DNA) samples will be obtained before, during and after treatment to quantify the change in microbial alfa diversity using statistical methods such as Shannon Diversity Index and Microbiome Health Index
#…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!